Type: Myeloma
Recent research has found that androgens (such as testosterone) can activate an important anti-cancer immune response in prostate cancer cells.
Dr Michelle McDonald and her team are in a unique position to examine how some drugs help to keep cancer cells in bone at bay.
Dr Micklethwaite has been developing myeloma-specific CAR T-cells – immune cells specifically designed to recognise and destroy myeloma cells.
Professor Croucher and his team have demonstrated the potential of a newly approved treatment for osteoporosis to strengthen and rebuild bone damaged by myeloma.